NTBL (Notable Labs Inc.) Gross Profitability

The gross margin distribution of Notable Labs, Ltd. (NTBL) demonstrates the biotech sector's resilience to crises, where 0.00 reflects the latest metric value. Business efficiency is based on the medical community's recognition of its algorithms and access to biological samples. Current growth relies on the expansion of IT models and B2B contracts with hospitals, which determines the company's market value through the lens of its profitability.
Analytical breakdowns and data insights for company Notable Labs, Ltd. (NTBL)

For Notable Labs, Ltd. (NTBL), which develops precision oncology therapy through functional live-cell diagnostics, this indicator reflects the monetization efficiency of personalized treatment. The metric is calculated as the difference between total revenue and direct test production costs, determining the portion of capital available to cover operating expenses. By analyzing the gross profit margin, an investor identifies the scalability of the business model and the risk of erosion of the asset's intrinsic value.